134 related articles for article (PubMed ID: 30947375)
41. Farnesyltransferase inhibitors: a detailed chemical view on an elusive biological problem.
Sousa SF; Fernandes PA; Ramos MJ
Curr Med Chem; 2008; 15(15):1478-92. PubMed ID: 18537624
[TBL] [Abstract][Full Text] [Related]
42. Cyclic nucleotide phosphodiesterase type 4 inhibitors: evaluation of pyrazolo[1,5-a]-1,3,5-triazine ring system as an adenine bioisostere.
Raboisson P; Schultz D; Muller C; Reimund JM; Pinna G; Mathieu R; Bernard P; Do QT; Desjarlais RL; Justiano H; Lugnier C; Bourguignon JJ
Eur J Med Chem; 2008 Apr; 43(4):816-29. PubMed ID: 17640774
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and structure-activity relationships of novel benzofuran farnesyltransferase inhibitors.
Asoh K; Kohchi M; Hyoudoh I; Ohtsuka T; Masubuchi M; Kawasaki K; Ebiike H; Shiratori Y; Fukami TA; Kondoh O; Tsukaguchi T; Ishii N; Aoki Y; Shimma N; Sakaitani M
Bioorg Med Chem Lett; 2009 Mar; 19(6):1753-7. PubMed ID: 19217288
[TBL] [Abstract][Full Text] [Related]
44. vHTS and 3D-QSAR for the Identification of Novel Phyto-inhibitors of Farnesyltransferase: Validation of Ascorbic Acid inhibition of Farnesyltransferase in an Animal Model of Breast Cancer.
Samuel Metibemu D
Drug Res (Stuttg); 2021 Jul; 71(6):341-347. PubMed ID: 33862663
[TBL] [Abstract][Full Text] [Related]
45. Antimycobacterial activity: synthesis of novel 3-(substituted phenyl)-6,7-dimethoxy-3a,4-dihydro-3H-indeno[1,2-c]isoxazole analogues.
Ali MA; Ismail R; Choon TS; Pandian S; Hassan Ansari MZ
J Enzyme Inhib Med Chem; 2011 Aug; 26(4):598-602. PubMed ID: 21714764
[TBL] [Abstract][Full Text] [Related]
46. Different amino acid replacements in CAAX-tetrapeptide based peptidomimetic farnesyltransferase inhibitors.
Schlitzer M; Sattler I; Dahse HM
Arch Pharm (Weinheim); 1999 Apr; 332(4):124-32. PubMed ID: 10327885
[TBL] [Abstract][Full Text] [Related]
47. Impact on farnesyltransferase inhibition of 4-chlorophenyl moiety replacement in the Zarnestra series.
Angibaud P; Mevellec L; Meyer C; Bourdrez X; Lezouret P; Pilatte I; Poncelet V; Roux B; Merillon S; End DW; Van Dun J; Wouters W; Venet M
Eur J Med Chem; 2007 May; 42(5):702-14. PubMed ID: 17316920
[TBL] [Abstract][Full Text] [Related]
48. Synthesis and biological evaluation of novel 1,2,4-triazine derivatives bearing carbazole moiety as potent α-glucosidase inhibitors.
Wang G; Wang J; He D; Li X; Li J; Peng Z
Bioorg Med Chem Lett; 2016 Jun; 26(12):2806-2809. PubMed ID: 27177827
[TBL] [Abstract][Full Text] [Related]
49. Design, synthesis and early structure-activity relationship of farnesyltransferase inhibitors which mimic both the peptidic and the prenylic substrate.
Schlitzer M; Böhm M; Sattler I; Dahse HM
Bioorg Med Chem; 2000 Aug; 8(8):1991-2006. PubMed ID: 11003144
[TBL] [Abstract][Full Text] [Related]
50. Green approach for the synthesis of thiophenyl pyrazoles and isoxazoles by adopting 1,3-dipolar cycloaddition methodology and their antimicrobial activity.
Sowmya DV; Lakshmi Teja G; Padmaja A; Kamala Prasad V; Padmavathi V
Eur J Med Chem; 2018 Jan; 143():891-898. PubMed ID: 29227929
[TBL] [Abstract][Full Text] [Related]
51. Discovery of 4-arylamido 3-methyl isoxazole derivatives as novel FMS kinase inhibitors.
Im D; Jung K; Yang S; Aman W; Hah JM
Eur J Med Chem; 2015 Sep; 102():600-10. PubMed ID: 26318067
[TBL] [Abstract][Full Text] [Related]
52. New FAAH inhibitors based on 3-carboxamido-5-aryl-isoxazole scaffold that protect against experimental colitis.
Andrzejak V; Muccioli GG; Body-Malapel M; El Bakali J; Djouina M; Renault N; Chavatte P; Desreumaux P; Lambert DM; Millet R
Bioorg Med Chem; 2011 Jun; 19(12):3777-86. PubMed ID: 21612933
[TBL] [Abstract][Full Text] [Related]
53. Synthesis and structure-activity relationships for 1-(4-(piperidin-1-ylsulfonyl)phenyl)pyrrolidin-2-ones as novel non-carboxylate inhibitors of the aldo-keto reductase enzyme AKR1C3.
Heinrich DM; Flanagan JU; Jamieson SM; Silva S; Rigoreau LJ; Trivier E; Raynham T; Turnbull AP; Denny WA
Eur J Med Chem; 2013 Apr; 62():738-44. PubMed ID: 23454516
[TBL] [Abstract][Full Text] [Related]
54. Guiding farnesyltransferase inhibitors from an ECLiPS library to the catalytic zinc.
Huang CY; Stauffer TM; Strickland CL; Reader JC; Huang H; Li G; Cooper AB; Doll RJ; Ganguly AK; Baldwin JJ; Rokosz LL
Bioorg Med Chem Lett; 2006 Feb; 16(3):507-11. PubMed ID: 16289818
[TBL] [Abstract][Full Text] [Related]
55. 1,3-Disubstituted and 1,3,3-trisubstituted adamantyl-ureas with isoxazole as soluble epoxide hydrolase inhibitors.
Burmistrov V; Morisseau C; Danilov D; Harris TR; Dalinger I; Vatsadze I; Shkineva T; Butov GM; Hammock BD
Bioorg Med Chem Lett; 2015 Dec; 25(23):5514-9. PubMed ID: 26520661
[TBL] [Abstract][Full Text] [Related]
56. Cu-mediated N-arylation of 1,2,3-triazin-4-ones: synthesis of fused triazinone derivatives as potential inhibitors of chorismate mutase.
Shiva Kumar K; Adepu R; Sandra S; Rambabu D; Rama Krishna G; Malla Reddy C; Misra P; Pal M
Bioorg Med Chem Lett; 2012 Jan; 22(2):1146-50. PubMed ID: 22189133
[TBL] [Abstract][Full Text] [Related]
57. Synthesis, biological evaluation, and docking studies of novel 5,6-diaryl-1,2,4-triazine thiazole derivatives as a new class of α-glucosidase inhibitors.
Wang G; Peng Z; Gong Z; Li Y
Bioorg Chem; 2018 Aug; 78():195-200. PubMed ID: 29587132
[TBL] [Abstract][Full Text] [Related]
58. Design, Synthesis and Biological Evaluation of Stilbene Derivatives as Novel Inhibitors of Protein Tyrosine Phosphatase 1B.
He H; Ge Y; Dai H; Cui S; Ye F; Jin J; Shi Y
Molecules; 2016 Dec; 21(12):. PubMed ID: 27999292
[TBL] [Abstract][Full Text] [Related]
59. A structure-activity relationship study of 1,2,4-triazolo[1,5-a][1,3,5]triazin-5,7-dione and its 5-thioxo analogues on anti-thymidine phosphorylase and associated anti-angiogenic activities.
Bera H; Tan BJ; Sun L; Dolzhenko AV; Chui WK; Chiu GN
Eur J Med Chem; 2013 Sep; 67():325-34. PubMed ID: 23871912
[TBL] [Abstract][Full Text] [Related]
60. Optimization of triazine nitriles as rhodesain inhibitors: structure-activity relationships, bioisosteric imidazopyridine nitriles, and X-ray crystal structure analysis with human cathepsin L.
Ehmke V; Winkler E; Banner DW; Haap W; Schweizer WB; Rottmann M; Kaiser M; Freymond C; Schirmeister T; Diederich F
ChemMedChem; 2013 Jun; 8(6):967-75. PubMed ID: 23658062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]